EntryPoint Capital »

Fulcrum Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $171k 15k 11.31

More positions owned by EntryPoint Capital

Charles Schwab Corporation (SCHW)
PNC Financial Services (PNC)
Ameriprise Financial (AMP)
Target Corporation (TGT)
Ares Management Corporation Cl A Com Stk (ARES)
UMH Properties (UMH)
Vici Pptys (VICI)
TJX Companies (TJX)
Service Corporation International (SCI)
Zoetis Cl A (ZTS)
Honeywell International (HON)
State Street Corporation (STT)
Marsh & McLennan Companies
News Corp Cl A (NWSA)
RBC Bearings Incorporated (RBC)

View all positions for EntryPoint Capital

Top funds holding Fulcrum Therapeutics

Suvretta Capital Management
RA Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Point72 Asset Management
Siren
D. E. Shaw & Co
First Turn Management
Adage Capital Partners GP
Ikarian Capital
ADAR1 Capital Management
Citadel Advisors

View all funds holding Fulcrum Therapeutics